On July 1, 2025, Exclcirc (Suzhou) Biomedical Co., Ltd. held a grand relocation ceremony. Moving from the incubator of the National Center of Technology Innovation for Biopharmaceuticals to Building A7, Zone I of Suzhou Industrial Park (BioBAY), the company now has its brand-new experimental and office base. This milestone marks a solid step forward for the company on its path of innovative development and ushers in a new chapter. 

Since its establishment in August 2023, Exclcirc biomed has made a name for itself in the circRNA field by virtue of its professional team, cutting-edge technology and innovative concepts. The company has always been committed to R&D and innovation, focusing on the R&D of circRNA-related platform technologies and the construction of pipelines, and has developed an enhanced circRNA platform and a series of pipelines. In less than two years, the company has achieved several key technological breakthroughs, with 2 projects having entered the preclinical research stage. It has also established in-depth cooperative relationships with a number of well-known scientific research institutions and enterprises, successfully completed a number of high-difficulty projects, and built a good reputation in the industry. 

On the day of the relocation, many peers from the biomedical industry and cooperative units that have long supported the company's development came to offer their congratulations and witnessed this exciting moment together. The atmosphere at the event was warm. The guests highly praised the company's development achievements and expressed high expectations for its future development in the new environment. Everyone agreed that the high-quality resources and sound ecosystem of BioBAY will inject strong impetus into Exclcirc Biomed's development and help the company achieve greater breakthroughs in the biomedical field. 

Dr. Dai Dongsheng, Founder, Chairman & CEO of Exclcirc Biomed, delivered a passionate speech at the relocation ceremony. He expressed sincere gratitude to all the guests for their presence and reviewed the company's development history since its establishment. He said, "The relocation to the new site is an important milestone in the company's development and a new starting point for us to move towards higher goals. Taking this opportunity, we will make full use of the resource advantages of BioBAY, increase R&D investment, enhance innovation capabilities, strengthen team building, and work hand in hand with enterprises in the park to contribute to the development of China's biomedical industry." 

Looking forward to the future, Exclcirc Biomed will continue to uphold the concept of innovation-driven development and benefiting patients on the vibrant and innovative environment of BioBAY. It will continuously enhance its own strength, accelerate the transformation of innovative achievements, and strive to become a leading enterprise in the biomedical field. The company will actively participate in the construction of the industrial ecosystem in the park and work with partners from all parties to explore innovative development models and make greater contributions to the progress of human health.